Breathalyser app diagnoses disease


Tuesday, 01 August, 2017



Breathalyser app diagnoses disease

Imagine if diagnosing a disease was as easy as breathing into a phone app. No needles and blood samples, no delayed diagnosis. This may soon be possible thanks to new technology developed in South Korea. 

Leveraging a phone app, the researchers use gas concentrations in human breath to diagnose certain diseases.

Working under Professor Il-Doo Kim, the Korea Advanced Institute of Science and Technology (KAIST) research team has developed diagnostic sensors using protein-encapsulated nanocatalysts, which can diagnose certain diseases by analysing biomarker gases in a person’s exhaled breath.

Human breath contains diverse components including water vapour, hydrogen, acetone, toluene, ammonia, hydrogen sulfide and carbon monoxide, some of which are closely related to diseases such as asthma, lung cancer, type 1 diabetes mellitus and halitosis.

The researchers started the process by capturing exhaled breaths in a Tedlar bag and the captured breath gases were subsequently injected into a miniaturised sensor system, similar to an alcohol breathalyser. It was then possible to rapidly analyse exhaled breath with a simple process that detects trace changes in exhaled breath components, contributing to early diagnosis of diseases.

The research team developed a disease diagnosis platform that recognises individual breathing patterns by using a multisensor array system with diverse sensing layers and heterogeneous catalysts, so that the people can easily identify health abnormalities. Using a 16-sensor array system, physical conditions can be continuously monitored by analysing concentration changes of biomarkers in exhaled breath gases.

Professor Kim said, “New types of heterogeneous nanocatalysts were synthesised using protein templates with sizes around 2 nm and functionalised on various metal oxide nanofibre-sensing layers. The established sensing libraries can detect biomarker species with high sensitivity and selectivity.

“The new and innovative breath gas analysis platform will be very helpful for reducing medical expenditures and continuous monitoring of physical conditions.”

Patents related to this technology were licensed to two companies in March and June this year.

The study’s results were published in the Journal of the American Chemical Society

Image caption: The sensing device can diagnose certain diseases. Image credit: KAIST.

Related Articles

How AI can help prevent physician burnout

AI is powering ambient clinical intelligence — it listens securely to...

Visualising mHealth in 2019

Mobile devices are becoming an increasingly important part of modern healthcare delivery.

Ransomware attack on Vic hospitals exposes vulnerabilities

Recent ransomware attacks serve as critical reminders of the fragmentation of health services in...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd